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OBJECTIVES: To evaluate the use of influenza vaccine in 
nursing homes and its effectiveness in reducing the likelihood 
of influenza-like illness. 
DESIGN: A retrospective case-control study with active iden- 
tification of influenza infection. 
SETTING: All nursing homes in a seven-county study area in 
southern lower Michigan were eligible for participation. 
Analyses were based on data collected from 23 homes with 
documented influenza transmission. 
PARTICIPANTS: Persons aged 65 years or older who were 
residents of the nursing homes under study during the influ- 
enza type A(H3N2) outbreak in 1989-1990. 
MEASUREMENTS: Residents were identified as cases or 
controls based on occurrence of febrile respiratory illness 
meeting a case definition. Demographic and underlying ill- 
ness information were gathered as were data on the use of 
influenza vaccine, antibiotics, and antivirals. Characteristics 
of the nursing homes were also recorded. Logistic regression 
analyses were carried out to determine vaccine effectiveness. 
MAIN RESULTS: Determinants of vaccine use were different 
from those observed in a parallel community-based study. In 
a multivariate model that considered the effects of resident 
and nursing home characteristics, vaccinated residents were 
significantly less likely than those who were not vaccinated to 
have an influenza-like illness (OR = .58 (95% CI, .43-.78), 
P < .001, imputed vaccine effectiveness estimate of 42%). 
Vaccination was more effective in younger residents (those 
aged 65 to 84) then in older residents (those older than 84 
years). 
CONCLUSIONS: Influenza vaccination was effective in re- 
ducing the likelihood of influenza-like illness in nursing home 
residents. Effectiveness appeared to be related to age, which 
may function as a surrogate for related immunologic factors. 
Older nursing home residents should be targeted for newer 
vaccines and/or potential prophylactic use of antivirals. J Am 
Gcriatr SOC 47:165-171, 1999. 
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nactivated influenza vaccines have been in use for more I than 50 years. Repeated controlled evaluations of their 
efficacy in young adults, typically military recruits, demon- 
strated prevention of laboratory-confirmed clinical disease in 
the range of 70 to 90%.' Until recently, many have ques- 
tioned the value of influenza vaccination in an older, more 
frail population because of the occurrence of nursing home 
outbreaks even in situations where the circulating virus was 
similar to that in the ~ a c c i n e . ~ - ~  A series of observational 
studies have confirmed that, in older persons living in the 
community, the vaccine has been significantly protective 
against outcomes such as hospitalization and, in some cases, 
death?-* Largely as a result of these studies, influenza vacci- 
nation became a Medicare part B-covered benefit in 1993.9 
The situation in nursing homes may be the most extreme 
test for the current vaccine since, in addition to the increased 
possibility for spread of infection in these closed environ- 
ments, many residents are older than 85 years of age and have 
multiple underlying conditions. l o  Most influenza-associated 
deaths occur among older people, and residents of nursing 
homes are at especially high risk for severe influenza-related 
complications. Since the emergence of influenza type 
A(H3N2) in 1968, seasons dominated by this influenza virus 
subtype have been associated with the highest mortality 
compared with seasons dominated by influenza type 
A(HlN1) or type B viruses. The outbreak during the 1989- 
1990 influenza season was more severe than that of the 
average A(H3N2) season, with major pneumonia and influ- 
enza mortality among older people nationally and increased 
morbidity in younger individuals." In an assessment of the 
impact of influenza epidemics on mortality in the United 
States from 1972 through 1992, using a severity index rang- 
ing from 1 (mildest) to 10 (most severe), the 1989-1990 
season was in severity category 6, one categor below the 
type A(H3N2) pandemic of 1968-1969." Influenza 
A(H3N2) viruses isolated nationally were antigenically sim- 
ilar to A/Shanghai/l1/87, the A(H3N2) component of the 
1989-1990 influenza vaccine. The current report describes 
an evaluation that estimated the effectiveness of the vaccine in 
preventing influenza-like illness in residents of nursing homes 
experiencing outbreaks of the type A(H3N2) virus using 
case-control methodology. 
METHODS 
Survcillancc 
The study area consisted of seven counties in south- 
central and southwestern lower Michigan. A community- 
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based surveillance system was established within this area 
from November through April to determine the timing and 
intensity of influenza virus activity and influenza-like ill- 
ness.I3 All 83 nursing homes in the seven-county study area 
were eligible and encouraged to participate in surveillance by 
reporting weekly on the number of new cases of influenza- 
like illness occurring among residents. Influenza-like illness 
(ILI) was defined as an oral temperature (or rectal or axillary 
equivalent) of at  least 37.8"C and one or more of the follow- 
ing signs or symptoms: cough, sore throat, or c o r y ~ a . ' ~  
Nursing homes were also asked to submit pharyngeal swab 
specimens for influenza isolation from residents with 
influenza-like illness; however, influenza virus isolation was 
not required to meet the case definition. 
After the period of influenza surveillance ended, the 
weekly incidence of influenza-like illness activity within each 
participating nursing home was evaluated. Homes that expe- 
rienced outbreaks (10% or more of the resident population 
developed ILI within a 7-day period during periods of 
laboratory-confirmed community influenza activity) and 
homes with definitive influenza introduction, based on influ- 
enza virus isolation from pharyngeal swab specimens, were 
targeted for enrollment in the vaccine effectiveness study. All 
homes recruited for the effectiveness study were required to 
have kept patient-specific logs throughout the surveillance 
period on those residents who met the case definition for ILL 
Study Population 
The eligible study population was comprised of all per- 
sons aged 65 years and older who were residents of partici- 
pating nursing homes, as determined from census lists, at  the 
beginning of the surveillance period, November 1,1989. All 
homes conducted influenza vaccination programs from late 
September through early November 1989, and residents' 
vaccination statuses resulting from these programs were con- 
sidered here. Cases were those residents who developed 
influenza-like illness during the period of laboratory- 
confirmed community influenza activity. Controls were 
drawn from the same study population and were required to 
have not developed ILI during the study period and to reside 
in the same facility as the case. Up to three controls were 
identified and group matched by 5-year age category to each 
identified case. Preference was given to selecting controls who 
resided in the same geographic area of the facility (wing or 
floor) as the case. Controls who died before the end of the 
surveillance period and controls who received amantadine 
were excluded, and, thus, selected controls had the opportu- 
nity to become cases throughout the surveillance period. 
Data Collection 
Data on cases and controls were collected retrospectively 
by nursing home staff using survey forms developed by study 
personnel. Data sources within nursing homes were individ- 
ual resident medical records, nurses' notes, pharmacy 
records, infection control logs, and the resident-specific case 
identification logs generated throughout the surveillance pe- 
riod. For each case or control, information about the follow- 
ing variables was requested: resident's gender, date of birth, 
admission date, date of onset of illness for cases, 1989-1990 
influenza vaccination status, pneumococcal vaccination sta- 
tus, the existence of certain chronic or comorbid conditions 
(heart disease, lung/pulmonary disease, diabetes, renal dis- 
ease, cancer, dementia, Parkinson's disease, hypothyroidism, 
and anemia), assessment of competency to give consent for 
their own medical treatment, amantadine use, antibiotic use, 
discharge status and date, and date of death, if applicable. 
Data Analysis 
Individuals were classified as vaccinated if their records 
indicated influenza vaccination for the 1989-1990 season 
during fall vaccination programs. Those whose records indi- 
cated not being vaccinated and those with unknown vaccina- 
tion status were coded as unvaccinated. Age was represented 
by six 5-year categories from 65 to 90 or older. Pneumococ- 
cal vaccination status was classified as vaccinated, unvacci- 
nated, or unknown. Specified chronic or comorbid condi- 
tions, as described previously, and competency to give 
consent for their own medical treatment were coded as 
present if reported as such, absent otherwise. Individuals who 
were discharged, transferred and/or who died were identified. 
Cases who died within 1 month of influenza-like illness onset 
were considered to have died as a result of influenza-related 
complications. Antibiotic and amantadine use were coded as 
present if reported as such, absent otherwise. 
In order to consider characteristics of individual nursing 
homes that might affect both the introduction of influenza 
into the home and transmission of influenza within the home, 
values for size of home (number of beds) and overall influenza 
vaccination level (percent vaccinated) for each participating 
nursing home were obtained from the 1989-1990 Nursing 
Home Survey" and included in this analysis. Number of beds 
was expressed as a dichotomous variable representing small 
(5100 beds) and large (> lo0  beds) homes, based on a 
frequency distribution of the number of beds. Percent vacci- 
nated was expressed as a dichotomous variable representing 
those homes above and below the overall median (and mean) 
of 75% vaccinated. 
The statistical significance of differences in characteris- 
tics between cases and controls and between vaccinated and 
unvaccinated individuals were evaluated using cross tabula- 
tions and chi-square statistics." Logistic regression analy- 
ses17 were used to estimate the effectiveness of influenza 
vaccination in reducing the likelihood of influenza-like illness 
while adjusting for study population and nursing home char- 
acteristics that influenced this relationship. Two techniques 
were used to control for the effect of individual nursing home 
characteristics on the evaluation of influenza vaccine effec- 
tiveness. The first technique used conditional logistic regres- 
sion to evaluate vaccine effectiveness conditional on nursing 
home. In this analysis, cases were compared only with con- 
trols within the same nursing home, and an overall measure 
of vaccine effectiveness was estimated. The second technique 
was developed for the purpose of considering the impact of 
theoretically important characteristics of nursing homes 
while estimating overall influenza vaccine effectiveness. Infor- 
mation on number of beds and overall percentage of 
influenza-vaccinated residents, as described previously, were 
selected to represent important features of nursing homes. 
Information on overall percentage of residents vaccinated 
was not available for five of the nursing homes represented in 
the case-control study. 
Estimates of the effectiveness of vaccine in preventing a 
rare condition in case-control studies can be derived from the 
logistic regression models as being equivalent to 1 minus the 
odds ratio (1-OR). Influenza-like illness in the present study 
was a relatively frequent outcome, suggesting that this deri- 
JAGS FERI1UARY 1999-VOL. 47, NO. 2 INFLUENZA VACCINE EFFECTIVENESS 167 
vation may not be directly appropriate. In order to permit 
comparison with the effectiveness measures derived in other 
studies, calculations that will be referred to as “imputed 
vaccine effectiveness estimates” are included here in addition 
to measures of reduced odds or likelihood. 
RESULTS 
Influenza Virus Activity 
Influenza A(H3N2) was the only type of influenza virus 
detected in the study area during the 1989-1990 season, and 
the strain was antigenically similar to the strain that circu- 
lated nationally and included as the A(H3N2) component of 
the 1989-1990 vaccine. Influenza was first isolated from a 
conimunity-acquired specimen in late November 1989; virus 
isolation continued through March 1990.13 The majority of 
the late season isolates were from nursing homes. Sixty-five 
(78%) study area homes participated in influenza-like illness 
surveillance by submitting weekly data on illness incidence. 
Thirty-one (37%) homes provided pharyngeal swab speci- 
mens for influenza virus isolation. 
Population Characteristics 
Because the underlying assumption of these analyses was 
that all included cases and controls were exposed to circulat- 
ing influenza virus, only homes with definitive introduction 
of influenza were included. Twenty-three nursing homes had 
evidence of influenza introduction based on outbreak activity 
(17 homes) or isolation of influenza virus from pharyngeal 
swab specimens (21 homes).Is This restriction resulted in a 
study population of 1198 residents: 361 cases (30%) and 837 
controls (70%). 
Table 1 shows the distribution of study population char- 
acteristics by case-control status. Overall, 71% of the study 
population were reported to have received the influenza 
vaccine for the 1989-1990 season; 61% of cases and 75% of 
controls received vaccine (OR = 5 2  (95% CI, .40-.67), 
imputed vaccine effectiveness estimate of 48%)). Women, 
who made up 80% of the total study population but only 
76% of the cases, were significantly less likely than men to 
develop ILI (OR = .74 (95% CI, 35-.99)). Cases and con- 
trols did not differ significantly by age categories as deter- 
mined in the study design. Pneumococcal vaccination con- 
firmed from nursing home records was identified in less than 
18% of the study population and did not differ by case or 
control status; pneumococcal vaccination status was un- 
known in 59% of the study population. Significantly more 
cases were reported to have lung disease (OR = 1.62 (95% 
CI, 1.05-2.50)) and renal disease (OR = 2.23 (95% CI, 
1.14-4.41)), whereas significantly more controls were as- 
sessed as being competent to give consent for their own 
medical treatment (OR = .61 (95% CI, .45-.82)). 
Table 1. Characteristics of the 1989-1390 Nursing Home Study Population by Casc and Control Status. South-central and 
Southwestern Lower Michigan 
Characteristic 
Cases 
n = 361 
Controls 
n = 837 P Value 
Gender 
Female 274 (75.9) 678 (81 .O) .045 
Male 87 (24.1) 159 (1 9.0) 
Age category 
65-69 15 (4.2) 52 (6.2) NS 
70-74 26 (7.2) 77 (9.2) 
75-79 51 (14.1) 124 (14.8) 
80-84 89 (24.7) 184 (22.0) 
85-89 89 (24.7) 192 (22.9) 
90+ 91 (25.2) 208 (24.9) 
Yes 220 (60.9) 628 (75.0) 
No 141 (39.1) 209 (25.0) 
Yes 64 (1 7.7) 144 (1 7.2) 
No 95 (26.3) 188 (22.5) 
Unknown 202 (56.0) 505 (60.3) 
Anemia 22 (6.1) 55 (6.6) NS 
Cancer 12 (3.3) 17 (2.0) NS 
Dementia 162 (44.9) 376 (44.9) NS 
Diabetes 45 (12.5) 106 (1 2.7) NS 
Heart disease 212 (58.7) 455 (54.4) NS 
Hypothyroidism 17 (4.7) 40 (4.8) NS 
Lung disease 37 (10.2) 55 (6.6) .028 
Parkinsons 21 (5.8) 49 (5.9) NS 
Influenza vaccination 1989-90 
Pneumococcal vaccination 
Cornorbid conditions (not mutually exclusive) 
Mentally competent 71 (19.7) 240 (28.7) .001 
Renal disease 16 (4.4) 17 (2.0) ,020 
NS = not statistically different, P > .05. 
c.001 
NS 
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Table 2 shows the distribution of study population char- 
acteristics by influenza vaccination status. Men were slightly, 
but not significantly, more likely to be vaccinated than wom- 
en. There were no significant differences in vaccination status 
by age category. Nursing home residents who were reported 
to have dementia (OR = 1.90 (95% CI, 1.47-2.45)) or 
Parkinson’s disease (OR = 2.31 (95% CI, 1.22-4.37)) were 
significantly more likely to be vaccinated than those without 
these conditions. Nursing home residents with renal disease 
(OR = .48 (95% CI, .25-.96)), lung disease (OR = 59 ,  (95% 
CI, .38-.91)), heart disease (OR = .75 (95% CI, 39-.97)), 
and those residents competent to give consent for their own 
treatment (OR = .75 (95% CI, 57-.99)) were significantly 
less likely to have received influenza vaccine. Residents whose 
medical records indicated that they had received pneumococ- 
cal vaccine were significantly more likely to have also re- 
ceived influenza vaccine (OR = 2.48 (95% CI, 1.63-3.77)). 
Influenza Vaccine Effectiveness 
Tables 3 and 4 show the results of two different logistic 
regression analyses used to estimate the effectiveness of influ- 
enza vaccination in reducing the likelihood of influenza-like 
illness among residents while adjusting for the effects of 
nursing home and resident characteristics. Table 3 presents 
the results of the conditional logistic regression. In this 
model, the odds ratio of 5 8  indicates a significant reduction 
Table 2. Characteristics of 1989-1990 Nursing Home Study 
Population by Influenza Vaccination Status. South-central and 
Southwestern Lower Michigan 
Influenza Vaccination Yes No 
Characteristic n = 848 n = 350 PValue 
Gender 
Female 
Male 
Age Category 
65- 69 
70-74 
75-79 
80-84 
85-89 
90 + 
Yes 
No 
Unknown 
Pneumococcal vaccination 
Comorbid conditions (not 
mutually exclusive) 
Anemia 
Cancer 
Dementia 
Diabetes 
Heart disease 
Hypothyroidism 
Lung disease 
Mentally competent 
Parkinsons 
Renal disease 
663 (78.2) 289 (82.6) 
185 (21.8) 61 (17.4) 
45 (5.3) 22 (6.3) 
66 (7.8) 37 (1 0.6) 
122 (14.4) 53 (15.1) 
193 (22.8) 80 (22.9) 
195 (23.0) 86 (24.6) 
227 (26.8) 72 (20.6) 
169 (19.9) 39 (11.1) 
180 (21.2) 103 (29.4) 
499 (58.8) 208 (59.4) 
52 (6.1) 25 (7.1) 
17 (2.0) 12 (3.4) 
41 9 (49.4) 1 19 (34.0) 
105 (12.4) 46 (13.1) 
455 (53.7) 212 (60.6) 
39 (4.6) 18 (5.1) 
55 (6.5) 37 (1 0.6) 
206 (24.3) 105 (30.0) 
59 (7.0) 11 (3.1) 
18 (2.1) 15 (4.3) 
NS 
NS 
<.001 
NS 
NS 
<.001 
NS 
.028 
NS 
.016 
.040 
.010 
.038 
NS = not statistically different, P > .05. 
Table 3. Conditional Logistic Regression Analysis of Influenza 
Vaccine Effectiveness in Preventing ILI in Nursing Homes with 
Proven Introduction of Influenza. 1989-1990 South-central and 
Southwest Lower Michigan 
Characteristic P Value Odds Ratio 95% CI 
Influenza vaccination c.001 .58 .43-.78 
1989-90 
Lung disease .059 1.61 .98-2.63 
Mental competence c.001 .56 .39-.76 
Renal disease .079 1.94 .93-4.07 
Imputed influenza vaccine effectiveness estimate 1-OR. 1-58 = 42%. 
Analysis adjusted for sex, age category, and conditional on individual nursing 
Analysis based on a sample size of 1198:361 cases and 837controls in 23 nursing 
home. 
homes. 
Table 4. Logistic Regression Analysis of Influenza Vaccine Effec- 
tiveness in Preventing ILI in a Subset of 18 Nursing Homcs with 
Proven Influenza Introduction and Complete Information, Using 
Overall Pcrcent Vaccinated and Number of Beds to Adjust for 
the Affect of Nursing Home on the Likelihood of ILL 1989- 
1990 South-central and Southwestern Lower Michigan 
Characteristic P Value Odds Ratio 95% CI 
Influenza vaccination <.001 58 .42-.79 
1989-90 
Lung disease .010 2.01 1.1 84.42 
Renal disease .160 1.77 .80-3.90 
Bed size .665 .93 .66-1.30 
Mental competence .003 59 .42-.84 
Percent vaccinated .069 .73 52-1.03 
Imputed influenza vaccine effectiveness estimate 1-OR. 1-58 = 42%. 
Analysis adjusted for sex and age category. 
Analysis based on a sample size of 922:282 cases and 640 controls in 18 nursing 
homes. 
for vaccinated individuals in the likelihood of having an 
influenza-like illness during the surveillance period (95% CI, 
.43-.78, P < .001, imputed vaccine effectiveness estimate of 
42%). Resident competency, but not lung or renal disease, 
remained significantly associated with the outcome in this 
model. This analysis was adjusted for sex and age category 
and was conditional on individual nursing home. 
Table 4 presents the results of the logistic regression 
analysis that considers the effect of potentially important 
nursing home characteristics on the likelihood of influenza- 
like illness among residents. The odds ratio of 5 8  associated 
with influenza vaccination again corresponds to a reduction 
in the odds of developing ILI among the vaccinated (95% CI, 
.42-.79, P < .001, imputed vaccine effectiveness estimate of 
42%). In this model, lung disease and resident competency 
were associated significantly with the outcome. Although 
nursing home size did not have an impact on the likelihood of 
influenza-like illness among residents, overall vaccination 
levels did. This effect, although not statistically significant, 
suggested reduction in the likelihood of illness among resi- 
dents of homes with higher overall vaccination levels. This 
analysis included only cases and controls from the nursing 
homes with information on overall percent vaccinated. When 
the original conditional logistic regression model was applied 
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to this subset population of 18  nursing homes, the odds ratio 
associated with influenza vaccination was estimated at  .64 
(P = .007, imputed vaccine effectiveness estimate of 36%). 
Vaccine effectiveness may be lower in older people be- 
cause of a number of factors, and extreme old age may be a 
surrogate for these factors. We evaluated vaccine effective- 
ness in two subsets of nursing home residents based on age 
group. The study population was divided into two approxi- 
mately equal subsets of residents: those 65 to 84 years old and 
those older than 84 years. The proportion of individuals who 
had received influenza vaccine was not significantly different 
between those aged 65 to 84 years and those more than 84 
years old (69% vs 73%, respectively, P = .15). Table 5 shows 
the results of the conditional logistic regression on the 
younger subset. Influenza vaccination was associated with a 
significant reduction in the odds of ILI in the younger age 
group (OR = .56 (95% CI, .37-.84), P = .005, imputed 
vaccine effectiveness estimate of 44%). Table 6 shows iden- 
tical analyses on the subset older than 84 years and although 
the analysis suggests reduced odds of ILI among the vacci- 
nated subjects, the estimate was not statistically significant 
(OR = .65 (95% CI, .42-1.01), P = .053, imputed vaccine 
effectiveness estimate of 35%). 
When cases of all ages were examined, it was found that 
75% were treated with antibiotics during their illness, al- 
though only 36 cases (10%) were identified as having pneu- 
monia in association with their influenza-like illness. Aman- 
tadine was used therapeutically in 70 cases in eight nursing 
homes; 90% of the treated cases resided in three homes. 
Thirty-three residents (9%) died within 1 month of influenza- 
like illness onset and were considered to have died as a result 
of influenza-related complications; overall, 45 cases (12%) 
died during the surveillance period. There were too few 
individuals who had influenza-related pneumonia or who 
died to evaluate the effectiveness of influenza vaccination in 
reducing the likelihood of these events. 
DISCUSSION 
Although inactivated influenza vaccines have been 
known for many years to be effective in preventing illness 
in young adults, the value of the vaccine in older individ- 
uals has continued to be q ~ e s t i o n e d . ~ - ~  For older persons 
living in the community, studies reported during the period 
1992-1995 using different methods in different popula- 
Table 5. Conditional Logistic Regression Analysis of Influenza 
Vaccine Effectiveness in Preventing ILI in a Subset of Nursing 
Home Residents ~ 8 5  Years Old, Living in Nursing Homes with 
Proven Introduction of Influenza. 1989-1990 South-central and 
Southwestern Lower Michigan 
Condition P Value Odds Ratio 95% CI 
Influenza vaccination .005 .56 .37 .84 
Lung disease .616 1.17 .63 2.17 
Mental competence .054 .64 .41 1.01 
Renal disease .I 85 2.1 1 .70 6.40 
1989-90 
Imputed influenza vaccine cffcctiveness estimate I-OR. 1-56  = 44%. 
Analysis adjusted for sex and conditional on individual nursing home. 
Analysis based on a sample size of 618:181 cases and 437controls in 22 nursing 
homes. The excluded home had no cases in the 4 5  years age group. 
Table 6. Conditional Logistic Regrcssion Analysis of Influenza 
Vaccine Effectiveness in Preventing ILI and Pneumonia in a 
Subset of Nursing Home Residents >84 Years Old, Living in 
Nursing Homes with Proven Introduction of Influenza. 1989- 
1990 South-central and southwestern Lower Michigan 
Condition P Value Odds Ratio 95% CI 
Influenza vaccination .053 -65 -42 1-01 
Lung disease .110 1.98 .86 4.55 
Mental competence C.001 .42 .25 .70 
Renal disease ,183 2.05 .71 5.86 
1989-90 
Imputed influenza vaccine effectiveness estimate 1-OR. 1-.65 = 35%, not 
Analysis adjusted for sex and conditional on individual nursing home. 
Analysis based on a sample size of 580:180 cases and 400 controls in 2 3  nursing 
significantly different from unity. 
homes. 
tions demonstrated that the vaccines were between 31  and 
57% effective in preventing hospitalization for illnesses 
diagnosed as pneumonia or influenza during the influenza 
season; in studies using a case control design, the range was 
31  to 45%.5-8 In all studies, the likelihood of these diag- 
noses actually representing illnesses caused by influenza 
was increased by timing the data collection to coincide 
with laboratory-defined influenza virus circulation. The 
cases were not identified by laboratory confirmation but by 
their having diagnoses considered compatible with influ- 
enza or an influenza-related complication. The consistency 
among these different studies is remarkable because the 
seasons were sometimes dominated by type B virus, and the 
exact clinical diagnostic categories considered in the indi- 
vidual studies varied. In all of these studies, there were 
unknown percentages of cases that were included but did 
not truly represent influenza-related illness, and this would 
lower estimates of vaccine effectiveness. 
In the current study, the primary outcome was also an  
epidemiologic one: an influenza-like illness meeting a 
broad case definition during a period of confirmed commu- 
nity influenza activity. To  increase the likelihood that 
influenza was the cause of illness in persons who met the 
case definition for ILI in this study, nursing homes were 
required to have evidence of introduction of the influenza 
virus to be included. However, because illnesses were not 
confirmed with influenza virus isolation, it is clear that our 
epidemiologic definition is not a clinical one and that some 
cases classified as ILI might not have actually been 
influenza-related illnesses." A large number of homes 
contributed data and thus can be considered to be broadly 
representative of all those in the region. Odds ratios gen- 
erated from logistic regression analyses were used to esti- 
mate the reduction in the likelihood of ILI among vac- 
cinated residents. Generally, estimates of vaccine 
effectiveness in preventing a rare condition in case control 
studies can be derived from the logistic regression models 
as being equivalent to 1 minus the odds ratios (1-OR). 
Inasmuch as ILI was not a rare outcome in the course of 
influenza outbreaks in the nursing homes described here, 
this derivation may not be directly appropriate. However, 
this was done to allow comparison with the results of other 
studies, especially since there is a body of opinion that 
views this derivation to approximate vaccine effectiveness 
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in this situation as a p p r ~ p r i a t e . ’ ~  Such a calculation is 
always considered appropriate when an entire cohort of 
eligible subjects is followed. 
The proportion of older nursing home residents who 
were vaccinated in this study was significantly greater than 
the vaccination levels among older community-dwelling res- 
idents reported in a companion study conducted during the 
same time period.” In addition, the likelihood of these nurs- 
ing home residents being vaccinated was not associated with 
the same chronic conditions as those operating in the com- 
munity. Nursing home residents with heart, lung, and renal 
disease and those able to give consent for their own treatment 
were actually significantly less likely to be vaccinated. This 
observation may be the result of differences in the way 
promotion of vaccination was carried out and agreement to 
be vaccinated was obtained in the community compared with 
nursing homes. 
An earlier study of influenza vaccine effectiveness in 
nursing homes using another study design found that vacci- 
nation was more effective in preventing severe outcomes than 
simple i l lne~s.’~ These comparisons were not possible in the 
current study because the number of severe events in those 
homes with documented influenza transmission was rela- 
tively small. There was evidence that protection of individual 
residents was increased indirectly by the vaccination level of 
the home, that is, by the effect of herd immunity. While not 
statistically significant in the model presented here, this rela- 
tionship has been found when the analysis was carried out at  
the nursing home level in which the effects of preventing 
introduction and subsequent spread were both measured.” 
No information was available on the percentage of nursing 
home staff members who were appropriately vaccinated be- 
fore the influenza season, although the importance of this 
factor in preventing introduction of influenza to residents 
should not be overlooked. 
Most interesting was the difference in prevention of 
illness when the population was dichotomized by age, with 
reduced effectiveness for influenza vaccination among the 
very old compared with those less than 85 years of age. It 
has been thought, with support from immunologic stud- 
ies,2l that outbreaks that occur even in well vaccinated 
nursing homes are related to the extreme old age of many 
of the residents. Although age alone may not be directly 
responsible for lower rates of effectiveness, it could func- 
tion as a surrogate for immunologic and other factors 
directly involved. It could be argued, then, that the very old 
should be among the highest priority groups for improved 
influenza vaccines, some of which are now under develop- 
ment. Like younger age, competency to give consent for 
their own medical treatment emerged as a factor suggesting 
better health status because competent individuals were 
both less likely to be vaccinated and less likely to be 
identified as cases. 
Of note also is that antibiotics were used in 75% of the 
cases even though only 10% were diagnosed as having 
pneumonia. Amantadine, the only licensed antiviral agent 
against influenza at  the time of this study, was used much 
less frequently and only in a small number of homes. This 
indicates a need to provide information and guidance 
about the use of rapid viral diagnostic testing and antiviral 
agents in the control of influenza to those who are respon- 
sible for medical care in nursing home facilities.” In par- 
ticular, antivirals for prophylaxis might be considered an 
adjunct to vaccination among the oldest residents in ap- 
propriate circumstances, given the limitations of the cur- 
rently available influenza vaccines in these  individual^.^^^^^ 
This would be of special relevance in those years in which 
the circulating type A strain is different from that in the 
vaccine. However, vaccine remains the primary control 
measure against influenza, and efforts should be made to 
increase its use among both nursing home residents and 
staff members to confer individual protection as well as 
indirect protection through herd immunity. As the distri- 
bution of vaccine among residents based on chronic med- 
ical conditions and other factors did not follow expected 
patterns in this study, it may be important to consider 
barriers to vaccine acceptance and to take action to over- 
come them so that the risk of both introduction and 
transmission of influenza in nursing homes can be reduced. 
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